Physician profile
Arya Namin
NPI 1023419405
$4,289.82
in general payments reported to CMS, 2019-2025
22 companies · $894 in 2025
The $894 reported for 2025 was more than what 77% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $23.77 · 2021: $138 · 2022: $2,007 · 2023: $253 · 2024: $311 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,458.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,500.00 | 2022 | |
| Stryker Corporation | $1,144.83 | 2019-2025 | Scopis Ent, Xpress Loprofile, Audion Et Dilation System |
| Depuy Synthes Sales INC. | $336.85 | 2021-2025 | Matrixmandible, Trumatch |
| Organogenesis INC. | $325.53 | 2021-2025 | Simplimax, Puraply |
| Inspire Medical Systems, INC. | $137.27 | 2022 | |
| Axogen | $124.01 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $122.78 | 2025 | Libtayo |
| Acera Surgical, INC. | $118.28 | 2024-2025 | Restrata Wound Matrix |
| Kerecis Limited | $88.29 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Glaxosmithkline, LLC. | $67.98 | 2019 | |
| Integra Lifesciences Corporation | $58.05 | 2023 | Integra, Microfrance, Integra Duo |
| Optinose US, INC. | $47.77 | 2023-2025 | |
| Janssen Biotech, INC. | $29.76 | 2024 | Talvey, Tecvayli, Darzalex |
| Novartis Pharmaceuticals Corporation | $27.85 | 2019 | |
| Intersect Ent, INC. | $26.75 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $24.66 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.81 | 2023 | Tagrisso |
| Emd Serono, INC. | $20.99 | 2023 | Bavencio |
| Merck Sharp & Dohme LLC | $17.27 | 2024 | Keytruda |
| Incyte Corporation | $16.53 | 2024 | Jakafi |
| Hologic Sales and Service, LLC | $16.45 | 2023 | Coolseal Generator |
| Aveo Pharmaceuticals, INC. | $16.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arya Namin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.